1. Home
  2. JG vs NEUP Comparison

JG vs NEUP Comparison

Compare JG & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Mobile Limited

JG

Aurora Mobile Limited

HOLD

Current Price

$5.56

Market Cap

35.2M

Sector

Technology

ML Signal

HOLD

NEUP

Neuphoria Therapeutics Inc.

HOLD

Current Price

$4.49

Market Cap

28.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
JG
NEUP
Founded
2012
1996
Country
China
United States
Employees
N/A
8
Industry
Computer Software: Programming Data Processing
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
35.2M
28.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
JG
NEUP
Price
$5.56
$4.49
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$21.00
AVG Volume (30 Days)
2.9K
57.0K
Earning Date
05-28-2026
05-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.00
$3.65
52 Week High
$12.74
$21.31

Technical Indicators

Market Signals
Indicator
JG
NEUP
Relative Strength Index (RSI) 37.31 35.02
Support Level $5.00 $3.91
Resistance Level $6.97 $4.56
Average True Range (ATR) 0.33 0.32
MACD -0.01 -0.10
Stochastic Oscillator 36.92 0.30

Price Performance

Historical Comparison
JG
NEUP

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates in one segment and generates revenues from SAAS Businesses.

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share on Social Networks: